Speaking to reporters from the White House Sunday, the Commander in Chief trolled reporters before announcing an emergency authorization of a coronavirus treatment.
President Donald Trump granted an emergency authorization for the usage of convalescent plasma to treat coronavirus patients, saying it is a “major breakthrough.”
“I hope you had a great weekend at your convention,” President Trump told the press, referring to last weeks Democratic National Convention. “And we’re gonna have a great convention coming up, and I look forward to it.”
TRUMP TO THE PRESS: “I hope you had a great weekend at your convention." pic.twitter.com/uLkdIK4pFM
— Benny (@bennyjohnson) August 23, 2020
Meanwhile, President Trump said on Sunday the FDA has “issued an emergency use authorization… for a treatment known as convalescent plasma.”
“This is a powerful therapy that transfuses very very strong antibodies from the blood of recovered patients to help treat patients battling a current infection,” he said, adding that the authorization will “expand access to this treatment.”
“Based on the science and the data, the FDA has made the independent determination that the treatment is safe and very effective,” President Trump said, before urging all recovered COVID-19 patients in the USA to donate their blood plasma. Video Below
The treatment takes convalescent plasma from patients who have recovered from the coronavirus and is rich in antibodies. Though it may provide benefits to those fighting the virus, the evidence has been inconclusive as to how it works or how best to administer it, as reported by Fox News.
The president on Saturday, however, tweeted: “The deep state, or whoever, over at the FDA is making it very difficult for drug companies to get people in order to test the vaccines and therapeutics. Obviously, they are hoping to delay the answer until after November 3rd. Must focus on speed, and saving lives!”
https://twitter.com/realDonaldTrump/status/1297138862108663808?s=20
President Donald Trump’s full remarks:
Continued Below
In announcing the emergency authorization for convalescent plasma, the FDA said its benefits “outweigh the known and potential risks of the product and that there are no adequate, approved, and available alternative treatments.”
Today, we issued an emergency use authorization (EUA) for investigational convalescent plasma for the treatment of hospitalized COVID-19 patients as part of the agency’s ongoing efforts to fight #COVID19. https://t.co/sxWrblWsxr pic.twitter.com/DnTrJaDTX1
— U.S. FDA (@US_FDA) August 23, 2020
We determined that it is reasonable to believe that #COVID19 convalescent plasma may be effective in lessening the severity or shortening the length of COVID-19 illness in some patients.
— U.S. FDA (@US_FDA) August 23, 2020
“I am committed to releasing safe and potentially helpful treatments for #COVID19 as quickly as possible in order to save lives.” – FDA Commissioner @SteveFDA
— U.S. FDA (@US_FDA) August 23, 2020
